 EXHIBIT 99.1 - TRANSACTION AGREEMENT      

    

 _Exhibit 99.1_

  



  

TRANSACTION AGREEMENT

  



  

This TRANSACTION AGREEMENT, dated as of April 4, 2007 (this "Agreement"), is
by and between Samuel J. Wohlstadter (the " _Stockholder_ ") and Roche
Holdings Ltd (" _Roche_ ").

  

 _RECITAL_

  

WHEREAS, Roche desires to purchase from the Stockholder and the Stockholder
desires to sell to Roche 1,000 shares of Series B Preferred Stock
(collectively referred to herein as the " _Shares_ ") of BioVeris Corporation,
a Delaware corporation (the " _Company_ "), and to enter into other agreements
as herein provided for the consideration and on the terms set forth in this
Agreement.

  

 _AGREEMENT_

  

NOW, THEREFORE, in consideration of the premises and mutual covenants,
conditions and agreements contained herein and for such other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto, each intending to be legally bound hereby,
agree as follows:

   

       



  |  

1.

  |  

_Transactions_. 

---|---|--- 
 

   

1.1 _Purchase and Sale of Shares_. Subject to the terms and
conditions of this Agreement, at the Closing (as defined in Section 1.5), the
Stockholder will sell and transfer to Roche and Roche will purchase and
acquire from the Stockholder, all of the Stockholders right, title and
interest in and to the Shares and any claims associated therewith.

  

1.2 _Release_. Effective immediately upon the Closing, the
Stockholder as to himself and his respective successors, assigns and heirs
hereby (a) releases, acquits and forever discharges the Company and its
respective successors, predecessors, assigns, heirs, officers, directors,
members of the board of managers, members, managers, employees, consultants
and trustees (in each case, solely in their capacities as such), in respect of
and from, and (b) agree not to bring any claim, suit, action, arbitration,
inquiry, investigation or other proceeding of any nature (whether criminal,
civil, legislative, administrative, regulatory, prosecutorial or otherwise) by
or before any arbitrator or governmental entity or similar person or body
against any such party (in each case, solely in their capacities as such)
related to or arising out of in the case of (a) and (b) above, any and all
claims, causes of action, suits, demands or liabilities or obligations, of
every name and nature, both at law and in equity, known or unknown, suspected
or unsuspected, accrued or unaccrued, which have been or could have been
asserted against the Company, or any such other persons, which Stockholder has
or ever had that arise out of or in any way relate to the Shares (including
the initial issuance and sale thereof).

  

1.3 _Other Agreements_. In connection with this Agreement, the
Stockholder has entered into a Non-Dislcosure and Non-Solicitation Agreement
with the Company as of the date hereof.

     

1.4 _Consideration_. In consideration of the agreements referred to
in Sections 1.1, 1.2 and 1.3 above, Roche agrees to pay to the Stockholder
$2,750,000 (the " _Consideration_ ").

  

1.5 _Closing_. The closing (the " _Closing_ ") contemplated by this
Agreement shall take place at the offices of Skadden, Arps, Slate, Meagher and
Flom LLP, 4 Times Square, New York, NY 10036, immediately prior to the
effective time as contemplated by that certain Agreement and Plan of Merger
dated as of the date hereof among Roche Holdings Ltd, Lili Acquisition
Corporation and the Company (the " _Merger Agreement_ ").

  

1.6 _Delivery_. At the Closing, (i) Roche shall pay to the
Stockholder the Consideration by wire transfer in immediately available funds
to an account designated by the Stockholder and (ii) the Stockholder shall
deliver to Roche a certificate or certificates representing the Shares,
endorsed in blank or accompanied by duly executed assignment documents.

  

2. _Representations, Warranties and Covenants of the Stockholder_. The Stockholder represents, warrants and covenants to Roche as follows:

  

2.1 _Power and Authority_. The Stockholder has full power and
authority to enter into this Agreement, perform his obligations hereunder,
sell the Shares and carry out the transactions contemplated herein. This
Agreement constitutes the legal, valid and binding obligation of the
Stockholder, enforceable against him in accordance with its terms, except (a)
as the enforcement thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws now or hereafter in effect
relating to creditors generally and (b) as limited by general principles of
equity that restrict the availability of equitable remedies.

  

2.2 _Title to the Shares_. The Stockholder is the record and
beneficial owner of the Shares. The Stockholder owns the Shares free and clear
of any claim, lien, option, pledge, security interest, right of first refusal,
or restriction of any kind, including any restriction on use, voting,
transfer, receipt of income, or exercise of any other attribute of ownership
(each an " _Encumbrance_ ").

  

2.3 _No Transfer; No Encumbrance_. The Stockholder shall not offer,
sell or otherwise dispose of any of the Shares prior to the Closing. The
Stockholder shall not cause the Shares to become subject to any Encumbrance
prior to the Closing.

  

3. _Representations and Warranties of Roche_. Roche represents and warrants to the Stockholder as follows:

  

3.1 _Corporate Power and Authority_. Roche has full power and
authority to enter into this Agreement, perform its obligations hereunder,
purchase the Shares and carry out the transactions contemplated herein. The
execution and delivery of this Agreement, the performance by Roche of its
obligations hereunder and the consummation of the transactions contemplated
herein have been duly authorized by all actions on the part of Roche required
by applicable law and its constituent documents. This Agreement constitutes
the legal, valid and binding obligation of Roche, enforceable against it in
accordance with its terms, except (a) as the enforcement thereof may be
limited by bankruptcy, insolvency, reorganization, moratorium or other similar
laws now or hereafter in effect relating to creditors generally and (b) as
limited by general principles of equity that restrict the availability of
equitable remedies.

  



  

2

      

       



  |  

4.

  |  

_Mutual Covenants; Closing Condition_. 

---|---|--- 
 

   

4.1 _Closing_. Subject to the conditions of this Agreement, the
Stockholder and Roche shall cause the Closing to occur immediately prior to
the effective time of the merger pursuant to the Merger Agreement.

  



  

4.2 _Public Announcements_. No press release or announcement
concerning the transactions contemplated hereby shall be issued by the
Stockholder or Roche or any of their affiliates without the prior consent of
the other party hereto, except as such press release or announcement may be
required by law, rule or regulation, in which case the party required to issue
the release or announcement shall, to the extent practicable, allow the other
party hereto reasonable time to comment on such release or announcement in
advance of the issuance of such release or announcement, or the press release
contemplated by the Merger Agreement.

  



  

4.3 _Closing Condition  Merger Agreement_. All of the conditions to
the closing of the Merger Agreement shall have been satisfied or waived,
except for those conditions that shall be satisfied at the closing of the
Merger Agreement, and each of the parties to the Merger Agreement shall have
notified each other party to the Merger Agreement, in writing (with copies of
such notices having been delivered to the parties hereto) that it is ready,
willing and able to consummate the transactions contemplated by the Merger
Agreement and that it intends to consummate the transactions contemplated by
the Merger Agreement immediately following the consummations of the
transactions contemplated by this Agreement.

  



  

5. _Termination_. Notwithstanding anything herein to the contrary, this Agreement shall be terminated automatically if, prior to the Closing, the Merger Agreement is terminated in accordance with its terms.

  



   

       



  |  

6.

  |  

_Miscellaneous_. 

---|---|--- 
 

   

6.1 _Notices_. All notices, requests and other communications to any
party hereunder shall be in writing and shall be deemed given if delivered
personally, facsimiled (which is confirmed) or sent by overnight courier
(providing proof of delivery) to the parties at the following addresses, which
addresses can be modified by providing written notice to the other party:

  

If to Roche, to:

  

Roche Holding Ltd

  

Grenzacherstrasse 124

  

CH-4070 Basel

  

Switzerland

  

Attention: General Counsel

  

Facsimile: +41 61 688 3196

  



  

3

     

 with a copy (which shall not constitute notice) to:

  

Davis Polk and Wardwell

  

450 Lexington Avenue

  

New York, NY 10017

  

Attention: Christopher Mayer, Esq.

  

Facsimile: 212-450-3800

  

If to the Stockholder, to:

  

c/o BioVeris Corporation

  

16020 Industrial Drive

  

Gaithersburg, MD 20877

  

Attention: President

  

Facsimile: (301) 230-0158

  



  

with a copy (which shall not constitute notice) to:

  

Kirkpatrick and Lockhart Preston Gates Ellis LLP

  

1601 K Street, NW

  

Washington, District of Columbia 20006-1600

  

Attention: Thomas F. Cooney, III, Esq.

  

Facsimile: (202) 778-9100

  



  

6.2 _Amendment; Waiver_. Neither this Agreement, nor any of the
terms or provisions hereof, may be amended, modified, supplemented or waived,
except by a written instrument signed by the parties hereto. No waiver of any
of the provisions of this Agreement shall be deemed or shall constitute a
waiver of any other provision hereof, nor shall such waiver constitute a
continuing waiver. No failure of either party to insist upon strict compliance
by the other party with any obligation, covenant, agreement or condition
contained in this Agreement shall operate as a waiver of, or estoppel with
respect to, any subsequent or other failure.

  

6.3 _Severability_. Each term and provision of this Agreement
constitutes a separate and distinct undertaking, covenant, term or provision
hereof. In the event that any term or provision of this Agreement shall be
determined to be unenforceable, invalid or illegal in any respect, such
unenforceability, invalidity, or illegality shall not affect any other term or
provision of this Agreement, but this Agreement shall be construed as if such
unenforceable, invalid or illegal term or provision had never been contained
herein.

  

6.4 _Entire Agreement_. This Agreement contains, and is intended as,
a complete statement of all the terms and arrangements between the parties
with respect to the matters provided for, supersedes any previous agreements
and understandings between the parties with respect to those matters and
cannot be changed or terminated orally.

  

6.5 _Governing Law_. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of Delaware, applicable to
contracts executed in and to be performed entirely in that state, without
regard to conflicts of laws principles.

  



  

4

     

6.6 _Counterparts_. This Agreement may be executed in one or more
counterparts, each of which will be deemed to be an original of the party
executing the same and all of which, when taken together, will be deemed to
constitute one and the same agreement.

  



  

[Signature Page Follows]

  



  

5

      

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed as of the day and year first above written.

  



   

       



  |  

ROCHE HOLDING LTD 

---|--- 
     



  |  



  |  


 
     



  |  

By:

  |  

/s/ Bruno Maier 

     



  |  



  |  

Name:

  |  

Bruno Maier 

     



  |  



  |  

Title:

  |  

Director 

     



  |  



  |  



  |  


 
     



  |  

By:

  |  

/s/ Beat Kraehenmann 

     



  |  



  |  

Name:

  |  

Beat Kraehenmann 

     



  |  



  |  

Title:

  |  

Director 

     



  |  



  |  



  |  


 
     



  |  



  |  



  |  


 
     



  |  

STOCKHOLDER: 

     



  |  



  |  



  |  



  |  


 
     

Shares of Common Stock

  |  



  |  

/s/ Samuel J. Wohlstadter 

     

Beneficially Owned: . . . . . . .

  |  

1000

  |  

SAMUEL J. WOHLSTADTER 

     



  |  



  |  



  |  


 
     



  |  



  |  



  |  


 
     



  |  



  |  



  |  


 
     



  |  



  |  



  |  


 
 

  



  



  



  



  



    



   

      '

